UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (233) 233
science & technology (233) 233
humans (211) 211
atrial fibrillation (185) 185
cardiovascular system & cardiology (163) 163
aged (131) 131
cardiac & cardiovascular systems (130) 130
female (129) 129
male (128) 128
anticoagulants (118) 118
risk factors (114) 114
stroke (109) 109
abridged index medicus (105) 105
warfarin (90) 90
anticoagulants - therapeutic use (81) 81
middle aged (81) 81
aged, 80 and over (79) 79
atrial fibrillation - drug therapy (75) 75
atrial fibrillation - complications (74) 74
stroke - prevention & control (74) 74
anticoagulants - adverse effects (70) 70
biological and medical sciences (70) 70
medical sciences (70) 70
peripheral vascular disease (65) 65
treatment outcome (63) 63
warfarin - therapeutic use (62) 62
anticoagulants - administration & dosage (56) 56
medicin och hälsovetenskap (53) 53
cardiac arrhythmia (51) 51
warfarin - adverse effects (51) 51
hemorrhage - chemically induced (50) 50
general & internal medicine (49) 49
drug therapy (48) 48
hematology (48) 48
medical and health sciences (48) 48
stroke - etiology (48) 48
anticoagulation (44) 44
hemorrhage (44) 44
cardiology. vascular system (43) 43
kardiologi (42) 42
cardiac and cardiovascular systems (41) 41
warfarin - administration & dosage (41) 41
medicine, general & internal (40) 40
risk assessment (40) 40
clinical medicine (39) 39
administration, oral (35) 35
cardiovascular (35) 35
care and treatment (35) 35
klinisk medicin (35) 35
mortality (35) 35
bleeding (34) 34
international normalized ratio (32) 32
heart (31) 31
atrial fibrillation - diagnosis (30) 30
follow-up studies (29) 29
thromboembolism (29) 29
thromboembolism - prevention & control (29) 29
atrial fibrillation - epidemiology (28) 28
incidence (28) 28
cardiology (27) 27
pharmacology. drug treatments (27) 27
prospective studies (27) 27
age factors (26) 26
analysis (26) 26
cardiac dysrhythmias (26) 26
registries (26) 26
time factors (26) 26
cohort studies (25) 25
dosage and administration (25) 25
patients (25) 25
thrombosis (24) 24
internal medicine (23) 23
prognosis (23) 23
united states (23) 23
apixaban (22) 22
atrial fibrillation - blood (22) 22
atrial fibrillation - physiopathology (22) 22
stroke - epidemiology (22) 22
complications and side effects (21) 21
medicine & public health (21) 21
neurology (21) 21
patient outcomes (21) 21
united states - epidemiology (21) 21
vascular diseases and vascular malformations of the nervous system (21) 21
adult (20) 20
medical research (20) 20
atrial fibrillation - therapy (19) 19
blood. blood coagulation. reticuloendothelial system (19) 19
fibrillation (19) 19
retrospective studies (19) 19
blood and lymphatic vessels (18) 18
cardiology and cardiovascular medicine (18) 18
diseases of the peripheral vessels. diseases of the vena cava. miscellaneous (18) 18
clinical trials (17) 17
fibrinolytic agents - therapeutic use (17) 17
medicine, experimental (17) 17
pyrazoles - therapeutic use (17) 17
pyridones - therapeutic use (17) 17
health aspects (16) 16
hemorrhage - epidemiology (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of arrhythmia, ISSN 1880-4276, 10/2017, Volume 33, Issue 5, pp. 369 - 409
Journal Article
The American heart journal, ISSN 0002-8703, 2010, Volume 159, Issue 3, pp. 331 - 339
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Neurology | Cardiac dysrhythmias | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Biological and medical sciences | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Blood and lymphatic vessels | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Follow-Up Studies | Humans | Middle Aged | Warfarin - adverse effects | Warfarin - therapeutic use | Young Adult | Fibrinolytic Agents - adverse effects | Thromboembolism - prevention & control | Fibrinolytic Agents - therapeutic use | Adult | Pyrazoles - adverse effects | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Adolescent | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Research Design | Pyridones - adverse effects | Stroke (Disease) | Clinical trials | Medical colleges | Warfarin | Atrial fibrillation | Risk factors | Health care | Anticoagulants | Cardiac arrhythmia | Stroke | Mortality | Thrombosis | Joint replacement surgery | Disease prevention | Blood platelets | Biomarkers | Blood pressure | Diabetes | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus | Pyrazoles | Pyridones | Factor Xa | Fibrinolytic Agents | Hemorrhage | Life Sciences | Thromboembolism | Atrial Fibrillation
Journal Article
5.